Latest Digital Generation Inc (DGIT) Headlines
Uptrend Call Working As DG FastChannel Stock Rises 69.6% (DGIT)
Comtex SmarTrend(R) - Mon Mar 10, 11:00AM CDT
SmarTrend identified an Uptrend for DG FastChannel (NASDAQ
GIT) on April 29th, 2013 at $7.12. In approximately 11 months, DG FastChannel has returned 69.64% as of today's recent price of $12.07.
DG FastChannel Has Returned 69.6% Since SmarTrend Recommendation (DGIT)
Comtex SmarTrend(R) - Mon Mar 03, 9:38AM CST
SmarTrend identified an Uptrend for DG FastChannel (NASDAQ GIT) on April 29th, 2013 at $7.12. In approximately 10 months, DG FastChannel has returned 69.64% as of today's recent price of $12.07.
Shares of DGIT Up 69.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 24, 9:16AM CST
SmarTrend identified an Uptrend for DG FastChannel (NASDAQ GIT) on April 29th, 2013 at $7.12. In approximately 10 months, DG FastChannel has returned 69.64% as of today's recent price of $12.07.
Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2013 Research Report
M2 - Thu Feb 06, 2:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/xcfqnn/anaplastic_large) has announced the addition of the "Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2013" report to their offering. 'Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL). Scope - A snapshot of the global therapeutic scenario for Anaplastic Large Cell Lymphoma (ALCL). - A review of the Anaplastic Large Cell Lymphoma (ALCL) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Anaplastic Large Cell Lymphoma (ALCL) pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Anaplastic Large Cell Lymphoma (ALCL) Overview Therapeutics Development Late Stage Products Clinical Stage Products Early Stage Products Assessment by Monotherapy Products Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Assessment by Therapeutic Class Drug Profiles brentuximab vedotin - Drug Profile crizotinib - Drug Profile SGN-30 - Drug Profile AKR-302 - Drug Profile CEP-28122 - Drug Profile CEP-37440 - Drug Profile AZD-3463 - Drug Profile KRA-0008 - Drug Profile AKR-303 - Drug Profile Small Molecules to Inhibit Aurora Kinase and ALK Kinase for Oncology - Drug Profile ALK Fusion Proteins Inhibitors - Drug Profile Anaplastic Large Cell Lymphoma (ALCL) - Recent Pipeline Updates Anaplastic Large Cell Lymphoma (ALCL) - Dormant Projects Anaplastic Large Cell Lymphoma (ALCL) - Product Development Milestones Featured News & Press Releases Companies Mentioned AstraZeneca PLC Seattle Genetics, Inc. Pfizer Inc. Teva Pharmaceutical Industries Limited Sareum Holdings plc Akron Molecules GmbH For more information visit http://www.researchandmarkets.com/research/xc...stic_large About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Sizmek to Report Fourth Quarter and Full Year 2013 Results, Host Conference Call and Webcast on February 18, 2014
Marketwire - Wed Feb 05, 11:39AM CST
Sizmek Inc., a wholly owned subsidiary of Digital Generation, Inc. (NASDAQ: DGIT), today announced that it will report its fourth quarter and full year 2013 financial results on Tuesday, February 18, 2014. The management will host a conference call and webcast at 05:00 pm ET that afternoon to review the results.
The New Online Company Changes Its Name to Sizmek Inc.
Marketwire - Tue Feb 04, 3:21PM CST
The New Online Company, a wholly owned subsidiary of Digital Generation, Inc. (NASDAQ: DGIT), the world's leading independent ad management and distribution platform, announced today that it will now operate around the world under the name Sizmek Inc. effective immediately.
Stockholders of Digital Generation, Inc. Approve Merger Agreement
Marketwire - Mon Feb 03, 3:32PM CST
Digital Generation, Inc. (NASDAQ: DGIT), the world's leading independent ad management and distribution platform, announced that at DG's special meeting of stockholders held today, stockholders voted overwhelmingly to approve the merger agreement by and among Extreme Reach, Inc., a wholly-owned subsidiary of Extreme Reach and DG.
Commit To Purchase Digital Generation At $10, Earn 6.8% Annualized Using Options
StockOptionsChannel.com - Fri Jan 31, 10:54AM CST
Investors considering a purchase of Digital Generation Inc shares, but tentative about paying the going market price of $13.67/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting...
Digital Generation, Inc. Announces Anticipated Closing Date for Merger Transaction
Marketwire - Tue Jan 28, 3:34PM CST
Digital Generation, Inc. (NASDAQ: DGIT), the world's leading ad management and distribution platform, today announced that the merger transaction with Extreme Reach, Inc. and a wholly-owned subsidiary of Extreme Reach is anticipated to close on February 7, 2014, subject to the satisfaction of the closing conditions set forth in the merger agreement, including approval and adoption of the merger agreement by the Company's stockholders at the special meeting of stockholders scheduled for February 3, 2014.
95.5% Return Seen to Date on SmarTrend DG FastChannel Call (DGIT)
Comtex SmarTrend(R) - Fri Jan 24, 9:09AM CST
SmarTrend identified an Uptrend for DG FastChannel (NASDAQ GIT) on April 29th, 2013 at $7.12. In approximately 9 months, DG FastChannel has returned 95.50% as of today's recent price of $13.91.
Uptrend Call Working As DG FastChannel Stock Rises 91.8% (DGIT)
Comtex SmarTrend(R) - Thu Jan 16, 4:48PM CST
SmarTrend identified an Uptrend for DG FastChannel (NASDAQ GIT) on April 29th, 2013 at $7.12. In approximately 9 months, DG FastChannel has returned 91.85% as of today's recent price of $13.65.
Titan Logix Corp. Reports Financial Results for Fiscal 2014 First Quarter
Marketwire Canada - Thu Jan 16, 4:28PM CST
Titan Logix Corp. (TSX VENTURE:TLA) ("Titan" or the "Company"), an advanced technology industrial instrumentation and controls company today reported its unaudited financial results for the first quarter of its fiscal 2014, ended November 30, 2013.
BIONOVA Skincare: Tennis Line
PR Newswire - Thu Jan 16, 9:10AM CST
Years ago, when BIONOVA emerged on the market, the concept of the brand and the proprietary technologies fascinated many people. One of them was a very reputable, distinguish and honorable man, Eugene Scott.
Digital Generation, Inc. Announces Filing of Definitive Proxy Statement
Marketwire - Tue Jan 14, 6:00AM CST
Digital Generation, Inc. (NASDAQ: DGIT), the world's leading ad management and distribution platform, today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission regarding the merger transaction with Extreme Reach, Inc. and a wholly-owned subsidiary of Extreme Reach and has set the date for a special meeting of stockholders to approve the transaction.
DisplayLink launches new USB 3.0 Docking Chipset featuring dual 2650x1600 resolution
PR Newswire - Tue Jan 07, 10:00AM CST
DisplayLink®, the leading provider of USB Graphics technology, today announced the official launch and products shipping with their new DL-3950 USB 3.0 Universal Docking Chipset. The latest chipset supports up to two 2560x1600 DisplayPort monitors along with Gigabit Ethernet, 5.1 channel audio, and is being demonstrated in the new Targus® ACP7101USZ at CES 2014.
Uptrend Call Working As DG FastChannel Stock Rises 69.6% (DGIT)
Comtex SmarTrend(R) - Mon Mar 10, 11:00AM CDT
SmarTrend identified an Uptrend for DG FastChannel (NASDAQ
GIT) on April 29th, 2013 at $7.12. In approximately 11 months, DG FastChannel has returned 69.64% as of today's recent price of $12.07. DG FastChannel Has Returned 69.6% Since SmarTrend Recommendation (DGIT)
Comtex SmarTrend(R) - Mon Mar 03, 9:38AM CST
SmarTrend identified an Uptrend for DG FastChannel (NASDAQ
GIT) on April 29th, 2013 at $7.12. In approximately 10 months, DG FastChannel has returned 69.64% as of today's recent price of $12.07. Shares of DGIT Up 69.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 24, 9:16AM CST
SmarTrend identified an Uptrend for DG FastChannel (NASDAQ
GIT) on April 29th, 2013 at $7.12. In approximately 10 months, DG FastChannel has returned 69.64% as of today's recent price of $12.07. Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2013 Research Report
M2 - Thu Feb 06, 2:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/xcfqnn/anaplastic_large) has announced the addition of the "Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2013" report to their offering. 'Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL). Scope - A snapshot of the global therapeutic scenario for Anaplastic Large Cell Lymphoma (ALCL). - A review of the Anaplastic Large Cell Lymphoma (ALCL) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Anaplastic Large Cell Lymphoma (ALCL) pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Anaplastic Large Cell Lymphoma (ALCL) Overview Therapeutics Development Late Stage Products Clinical Stage Products Early Stage Products Assessment by Monotherapy Products Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Assessment by Therapeutic Class Drug Profiles brentuximab vedotin - Drug Profile crizotinib - Drug Profile SGN-30 - Drug Profile AKR-302 - Drug Profile CEP-28122 - Drug Profile CEP-37440 - Drug Profile AZD-3463 - Drug Profile KRA-0008 - Drug Profile AKR-303 - Drug Profile Small Molecules to Inhibit Aurora Kinase and ALK Kinase for Oncology - Drug Profile ALK Fusion Proteins Inhibitors - Drug Profile Anaplastic Large Cell Lymphoma (ALCL) - Recent Pipeline Updates Anaplastic Large Cell Lymphoma (ALCL) - Dormant Projects Anaplastic Large Cell Lymphoma (ALCL) - Product Development Milestones Featured News & Press Releases Companies Mentioned AstraZeneca PLC Seattle Genetics, Inc. Pfizer Inc. Teva Pharmaceutical Industries Limited Sareum Holdings plc Akron Molecules GmbH For more information visit http://www.researchandmarkets.com/research/xc...stic_large About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Sizmek to Report Fourth Quarter and Full Year 2013 Results, Host Conference Call and Webcast on February 18, 2014
Marketwire - Wed Feb 05, 11:39AM CST
Sizmek Inc., a wholly owned subsidiary of Digital Generation, Inc. (NASDAQ: DGIT), today announced that it will report its fourth quarter and full year 2013 financial results on Tuesday, February 18, 2014. The management will host a conference call and webcast at 05:00 pm ET that afternoon to review the results.
The New Online Company Changes Its Name to Sizmek Inc.
Marketwire - Tue Feb 04, 3:21PM CST
The New Online Company, a wholly owned subsidiary of Digital Generation, Inc. (NASDAQ: DGIT), the world's leading independent ad management and distribution platform, announced today that it will now operate around the world under the name Sizmek Inc. effective immediately.
Stockholders of Digital Generation, Inc. Approve Merger Agreement
Marketwire - Mon Feb 03, 3:32PM CST
Digital Generation, Inc. (NASDAQ: DGIT), the world's leading independent ad management and distribution platform, announced that at DG's special meeting of stockholders held today, stockholders voted overwhelmingly to approve the merger agreement by and among Extreme Reach, Inc., a wholly-owned subsidiary of Extreme Reach and DG.
Commit To Purchase Digital Generation At $10, Earn 6.8% Annualized Using Options
StockOptionsChannel.com - Fri Jan 31, 10:54AM CST
Investors considering a purchase of Digital Generation Inc shares, but tentative about paying the going market price of $13.67/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting...
Digital Generation, Inc. Announces Anticipated Closing Date for Merger Transaction
Marketwire - Tue Jan 28, 3:34PM CST
Digital Generation, Inc. (NASDAQ: DGIT), the world's leading ad management and distribution platform, today announced that the merger transaction with Extreme Reach, Inc. and a wholly-owned subsidiary of Extreme Reach is anticipated to close on February 7, 2014, subject to the satisfaction of the closing conditions set forth in the merger agreement, including approval and adoption of the merger agreement by the Company's stockholders at the special meeting of stockholders scheduled for February 3, 2014.
95.5% Return Seen to Date on SmarTrend DG FastChannel Call (DGIT)
Comtex SmarTrend(R) - Fri Jan 24, 9:09AM CST
SmarTrend identified an Uptrend for DG FastChannel (NASDAQ
GIT) on April 29th, 2013 at $7.12. In approximately 9 months, DG FastChannel has returned 95.50% as of today's recent price of $13.91. Uptrend Call Working As DG FastChannel Stock Rises 91.8% (DGIT)
Comtex SmarTrend(R) - Thu Jan 16, 4:48PM CST
SmarTrend identified an Uptrend for DG FastChannel (NASDAQ
GIT) on April 29th, 2013 at $7.12. In approximately 9 months, DG FastChannel has returned 91.85% as of today's recent price of $13.65. Titan Logix Corp. Reports Financial Results for Fiscal 2014 First Quarter
Marketwire Canada - Thu Jan 16, 4:28PM CST
Titan Logix Corp. (TSX VENTURE:TLA) ("Titan" or the "Company"), an advanced technology industrial instrumentation and controls company today reported its unaudited financial results for the first quarter of its fiscal 2014, ended November 30, 2013.
BIONOVA Skincare: Tennis Line
PR Newswire - Thu Jan 16, 9:10AM CST
Years ago, when BIONOVA emerged on the market, the concept of the brand and the proprietary technologies fascinated many people. One of them was a very reputable, distinguish and honorable man, Eugene Scott.
Digital Generation, Inc. Announces Filing of Definitive Proxy Statement
Marketwire - Tue Jan 14, 6:00AM CST
Digital Generation, Inc. (NASDAQ: DGIT), the world's leading ad management and distribution platform, today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission regarding the merger transaction with Extreme Reach, Inc. and a wholly-owned subsidiary of Extreme Reach and has set the date for a special meeting of stockholders to approve the transaction.
DisplayLink launches new USB 3.0 Docking Chipset featuring dual 2650x1600 resolution
PR Newswire - Tue Jan 07, 10:00AM CST
DisplayLink®, the leading provider of USB Graphics technology, today announced the official launch and products shipping with their new DL-3950 USB 3.0 Universal Docking Chipset. The latest chipset supports up to two 2560x1600 DisplayPort monitors along with Gigabit Ethernet, 5.1 channel audio, and is being demonstrated in the new Targus® ACP7101USZ at CES 2014.
